Infections

Skin and Connective Tissue Diseases

All Conditions

Symptoms and General Pathology

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Warts

Communicable Diseases

Papillomavirus Infections

Virus Diseases

DNA Virus Infections

Skin Diseases

Skin Diseases, Viral

Tumor Virus Infections

Skin Diseases, Infectious

All Drugs and Chemicals

Resiquimod

Immunomodulating Agents

Immunologic Factors

The primary purpose of this study is to evaluate the effectiveness in adults, of four different strengths of resiquimod gel applied to common wart(s) three times a week for twelve weeks.

A second purpose is to evaluate the safety of the drug.

Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

A Three-Stage, Modified-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel for the Treatment of Common Warts in Adults

Graceway Pharmaceuticals, LLC

The primary purpose of this study is to evaluate the effectiveness in pediatric subjects of three different strengths of resiquimod gel applied to common wart(s) three times a week for four weeks.

A second purpose is to evaluate the safety of the drug.

Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects

A Single-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 3 Times Per Week for 4 Weeks for the Treatment of Common Warts in Pediatric Subjects

Spots Global Cancer Trial Database for wart(s)

Every month we try and update this database with for wart(s) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults	NCT00114920	Warts	Resiquimod	18 Years -	Graceway Pharmaceuticals, LLC
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects	NCT00116675	Warts	Resiquimod	3 Years - 11 Years	Graceway Pharmaceuticals, LLC
Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults	NCT00114920	Warts	Resiquimod	18 Years -	Graceway Pharmaceuticals, LLC

Spots Global Cancer Trial Database for wart(s)

Every month we try and update this database with for wart(s) cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for wart(s) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.